Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by BYRNE, P. A. C.
Right arrow Articles by PRITCHARD, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BYRNE, P. A. C.
Right arrow Articles by PRITCHARD, M. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 British Society for Rheumatology

case-report

MINOCYCLINE-RELATED LUPUS

P. A. C. BYRNE, B. D. WILLIAMS and M. H. PRITCHARD

Department of Rheumatology, University Hospital of Wales Cardiff CF4 4XW

Five cases of suspected drug-related lupus are described in young female patients who had been taking minocycline for several years. All were asymptomatic before starting treatment. After variable but prolonged periods of continuous therapy all abruptly developed arthralgia/arthritis and on testing were antinuclear factor positive. In four cases the symptoms and signs disappeared within a short time of stopping the drug, whereas in the remaining case the systemic nature of the illness required treatment with corticosteroids. Three patients who were rechallenged with minocycline quickly developed a recurrence of their joint symptoms. Resolution of the serological abnormalities noted in these patients occurred more slowly than the resolution of the clinical symptoms. We propose a direct relationship in these cases between minocycline therapy and the occurrence of a lupus-like syndrome.

KEY WORDS: Minocyline, Drug-related lupus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
T. M. Lawson, N. Amos, D. Bulgen, and B. D. Williams
Minocycline-induced lupus: clinical features and response to rechallenge
Rheumatology, March 1, 2001; 40(3): 329 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
R. Corona
Minocycline in Acne Is Still an Issue
Arch Dermatol, September 1, 2000; 136(9): 1143 - 1145.
[Full Text] [PDF]

Home page
 LupusHome page
N. J. McHugh
Minocycline-induced lupus and autoimmune phenomena
Lupus, July 1, 1999; 8(6): 417 - 418.
[PDF]

Home page
 ChestHome page
C. S. Christodoulou, P. Emmanuel, R. A. Ray, R. A. Good, B. M. Schnapf, and G. D. Cawkwell
Respiratory Distress Due to Minocycline-Induced Pulmonary Lupus
Chest, May 1, 1999; 115(5): 1471 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. C. J. M. Sturkenboom, C. R. Meier, H. Jick, and B. H. C. Stricker
Minocycline and Lupuslike Syndrome in Acne Patients
Arch Intern Med, March 8, 1999; 159(5): 493 - 497.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. J. Schrodt and J. P. Callen
Polyarteritis Nodosa Attributable to Minocycline Treatment for Acne Vulgaris
Pediatrics, February 1, 1999; 103(2): 503 - 504.
[Full Text]

Home page
 PediatricsHome page
E. Akin, L. C. Miller, and L. B. Tucker
Minocycline-induced Lupus in Adolescents
Pediatrics, May 1, 1998; 101(5): 926 - 928.
[Full Text] [PDF]

Home page
 BMJHome page
A. Gough, S. Chapman, K. Wagstaff, P. Emery, and E. Elias
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome
BMJ, January 20, 1996; 312(7024): 169 - 172.
[Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.